Results 171 to 180 of about 31,199 (226)

Fluorescence lifetime imaging ophthalmoscopy (FLIO) of patients with neovascular age-related macular degeneration before and after treatment with intravitreal ranibizumab. [PDF]

Graefes Arch Clin Exp Ophthalmol
Sonntag SR, Fries S, Gniesmer S, Grisanti S, Miura Y.   +4 more
europepmc   +1 more source

Artificial Intelligence-based characterization of therapeutic response in fluid types and volumes influencing retinal function in neovascular age-related macular degeneration. [PDF]

Sci Rep
Frank-Publig S, Buehl W, Mares V, Fuchs P, Coulibaly LM, Eidenberger A, Scheschy U, Faustmann G, Gumpinger M, Sükei E, Bogunovic H, Reiter GS, Sacu S, Schmidt-Erfurth U.   +13 more
europepmc   +1 more source

One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report. [PDF]

Ophthalmol Ther
Kitay AM, Tillmann A, Pfister I, Schild C, Bonanata M, Heck K, Spitznagel T, Gabathuler F, Bartolomeo N, Magnin S, Löliger J, Munk MR, Menghini M, Hatz K, Somfai GM, Zweifel S, Ambresin A, Eandi CM, Feltgen N, Weinberger A, Garweg JG, Kurz-Levin MM.   +21 more
europepmc   +1 more source

Association between systemic complement levels and choroidal thickness in advanced non-neovascular age-related macular degeneration. [PDF]

Sci Rep
E de Carlo Forest T, Marin AI, Gill Z, Gnanaraj R, Patnaik JL, Poppelaars F, Lynch AM, Palestine AG, Mathias MT, Manoharan N, Frazer-Abel AA, Holers VM, Mandava N.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neovascular Age-Related Macular Degeneration

Ophthalmologica, 2012
<i>Purpose:</i> Neovascular age-related macular degeneration (AMD) is a leading cause of blindness, with an increasing incidence as the elderly population expands. Large, multi-center, randomized, clinical trials have been conducted exploring the safety and efficacy of anti-VEGF treatments. This paper aims to discuss the safety and efficacy
VERITTI, Daniele, SARAO, Valentina, LANZETTA, Paolo   +2 more
openaire   +3 more sources

Neovascular Age-Related Macular Degeneration

Ophthalmology, 2013
Age-related macular degeneration (AMD) progresses through early and intermediate to advanced stages, one of which is neovascular AMD (nAMD). A correct diagnosis of nAMD at an early stage is critical because unlike geographic atrophy, it can be treated with therapeutic agents.
Bianca S. Gerendas, Julia S. Kroisamer, Florian Sulzbacher, Ursula Schmidt-Erfurth   +3 more
openaire   +2 more sources

Neovascular Age-Related Macular Degeneration

2015
Age-related macular degeneration (AMD) is the leading cause of severe vision loss in individuals over the age of 50 years. Choroidal neovascularization (CNV) is the hallmark of 'wet' or 'exudative' AMD, and is responsible for approximately 90% of cases of severe vision loss due to AMD. Vascular endothelial growth factor (VEGF) is a key component in the
Jack, Shao, Maria M, Choudhary, Andrew P, Schachat   +2 more
openaire   +3 more sources

Neovascular Age-Related Macular Degeneration

Drugs, 2008
Age-related macular degeneration (AMD) affects an estimated 14 million people worldwide, and is the leading cause of severe, irreversible vision loss in individuals over the age of 50 years in Western societies. Choroidal neovascularization (CNV), the hallmark of 'wet', 'exudative' or 'neovascular' AMD, is responsible for approximately 90% of cases of ...
Aimee V, Chappelow, Peter K, Kaiser
openaire   +2 more sources

Macular translocation for neovascular age-related macular degeneration

Cochrane Database of Systematic Reviews, 2008
Macular translocation has been proposed by vitreoretinal surgeons to displace the neuroretinal tissue onto healthy retinal pigment epithelium and choroid when the macula has been invaded by subretinal neovascularisation.This review aims at assessing the effectiveness of macular translocation for preserving or improving vision in patients with ...
Eandi CM, GIANSANTI, FABRIZIO, VIRGILI, GIANNI   +2 more
openaire   +3 more sources